Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001--2009 - PubMed (original) (raw)
. 2011 May 6;60(17):547-52.
- PMID: 21544044
Free article
Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001--2009
Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2011.
Free article
Abstract
Background: Most persons with asthma can be symptom-free if they receive appropriate medical care, use inhaled corticosteroids when prescribed, and modify their environment to reduce or eliminate exposure to allergens and irritants. This report reviews recent progress in managing asthma and reducing its prevalence in the United States.
Methods: CDC analyzed asthma data from the 2001--2009 National Health Interview Survey concerning children and adults, and from the 2001, 2005, and 2009 state-based Behavioral Risk Factor Surveillance System concerning adults.
Results: Among persons of all ages, the prevalence of asthma increased from 7.3% (20.3 million persons) in 2001 to 8.2% (24.6 million persons) in 2009, a 12.3% increase. Prevalence among children (persons aged <18 years) was 9.6%, and was highest among poor children (13.5%) and among non-Hispanic black children (17.0%). Prevalence among adults was 7.7%, and was greatest in women (9.7%) and in adults who were poor (10.6%). More uninsured persons with asthma than insured could not afford to buy prescription medications (40.3% versus 11.5%), and fewer uninsured persons reported seeing or talking with a primary-care physician (58.8% versus 85.6%) or specialist (19.5% versus 36.9%). Among persons with asthma, 34.2% reported being given a written asthma action plan, and 68.1% had been taught the appropriate response to symptoms of an asthma attack. Only about one third of children or adults were using long-term control medicine such as inhaled corticosteroids at the time of the survey. CONCLUSIONS AND COMMENT: Persons with asthma need to have access to health care and appropriate medications and use them. They also need to learn self-management skills and practice evidence-based interventions that reduce environmental risk factors.
Similar articles
- A multinational study of treatment failures in asthma management.
Burney P, Potts J, Aït-Khaled N, Sepulveda RM, Zidouni N, Benali R, Jerray M, Musa OA, El-Sony A, Behbehani N, El-Sharif N, Mohammad Y, Khouri A, Paralija B, Eiser N, Fitzgerald M, Abu-Laban R. Burney P, et al. Int J Tuberc Lung Dis. 2008 Jan;12(1):13-8. Int J Tuberc Lung Dis. 2008. PMID: 18173871 - Clinical and economic effects of suboptimally controlled asthma.
Bootman JL, Crown WH, Luskin AT. Bootman JL, et al. Manag Care Interface. 2004 Jan;17(1):31-6. Manag Care Interface. 2004. PMID: 15035598 - Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007.
National Asthma Education and Prevention Program. National Asthma Education and Prevention Program. J Allergy Clin Immunol. 2007 Nov;120(5 Suppl):S94-138. doi: 10.1016/j.jaci.2007.09.043. J Allergy Clin Immunol. 2007. PMID: 17983880 - Outpatient management of asthma in children age 5-11 years: guidelines for practice.
Watts B. Watts B. J Am Acad Nurse Pract. 2009 May;21(5):261-9. doi: 10.1111/j.1745-7599.2009.00403.x. J Am Acad Nurse Pract. 2009. PMID: 19432910 Review. - Evidence-based asthma management.
Kallstrom TJ. Kallstrom TJ. Respir Care. 2004 Jul;49(7):783-92. Respir Care. 2004. PMID: 15222910 Review.
Cited by
- Medication exposure in pregnancy risk evaluation program: the prevalence of asthma medication use during pregnancy.
Hansen C, Joski P, Freiman H, Andrade S, Toh S, Dublin S, Cheetham C, Cooper W, Pawloski P, Li DK, Beaton S, Kaplan S, Scott P, Hammad T, Davis R. Hansen C, et al. Matern Child Health J. 2013 Nov;17(9):1611-21. doi: 10.1007/s10995-012-1173-x. Matern Child Health J. 2013. PMID: 23108737 Free PMC article. - Relationships between folate and inflammatory features of asthma.
Lin JH, Matsui W, Aloe C, Peng RD, Diette GB, Breysse PN, Matsui EC. Lin JH, et al. J Allergy Clin Immunol. 2013 Mar;131(3):918-20. doi: 10.1016/j.jaci.2012.10.046. Epub 2012 Dec 11. J Allergy Clin Immunol. 2013. PMID: 23237419 Free PMC article. No abstract available. - Phenotyping of difficult asthma using longitudinal physiological and biomarker measurements reveals significant differences in stability between clusters.
Zaihra T, Walsh CJ, Ahmed S, Fugère C, Hamid QA, Olivenstein R, Martin JG, Benedetti A. Zaihra T, et al. BMC Pulm Med. 2016 May 10;16(1):74. doi: 10.1186/s12890-016-0232-2. BMC Pulm Med. 2016. PMID: 27165150 Free PMC article. - Interleukin-5 Antagonists Usher in a New Generation of Asthma Therapy.
Giannetti MP, Cardet JC. Giannetti MP, et al. Curr Allergy Asthma Rep. 2016 Nov;16(11):80. doi: 10.1007/s11882-016-0662-1. Curr Allergy Asthma Rep. 2016. PMID: 27796795 Review. - Using Video Telehealth to Facilitate Inhaler Training in Rural Patients with Obstructive Lung Disease.
Locke ER, Thomas RM, Woo DM, Nguyen EHK, Tamanaha BK, Press VG, Reiber GE, Kaboli PJ, Fan VS. Locke ER, et al. Telemed J E Health. 2019 Mar;25(3):230-236. doi: 10.1089/tmj.2017.0330. Epub 2018 Jul 17. Telemed J E Health. 2019. PMID: 30016216 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical